Journal
TRENDS IN MOLECULAR MEDICINE
Volume 10, Issue 9, Pages 440-444Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2004.07.009
Keywords
-
Funding
- NCRR NIH HHS [M01 RR 00633] Funding Source: Medline
- NIDDK NIH HHS [R01 DK 54387] Funding Source: Medline
Ask authors/readers for more resources
In 2001, a locus for autosomal-recessive congenital generalized lipodystrophy was identified on chromosome 11q13 and mutations in a novel gene named Berardinelli-Seip congenital lipodystrophy 2 (BSCL2) were reported. Earlier this year, heterozygous mutations in the BSCL2 gene, restricted to the N-glycosylation (N-X-S/T) motif, were reported in autosomal-dominant distal hereditary motor neuropathy and Silver syndrome, which are disorders with distinctly different phenotypes from lipodystrophy. BSCL2 encodes seipin, a transmembrane protein that is localized to the endoplasmic reticulum. It is proposed that its homology to midasin, an AAA (ATPases associated with various cellular activities) domain-containing nuclear protein that is involved in RNA transport, might yield some clues as to how mutant forms of seipin cause two clinically distinct syndromes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available